Sonali M Smith Selected Research

Sonali M Smith Research Topics

Disease

41	Lymphoma (Lymphomas) 01/2024 - 08/2003
23	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024 - 08/2006
21	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 09/2008
21	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023 - 11/2010
21	Neoplasms (Cancer) 11/2023 - 07/2006
20	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 02/2008
15	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 09/2008
13	Hodgkin Disease (Hodgkin's Disease) 01/2024 - 10/2010
9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 08/2003
8	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020 - 10/2013
6	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023 - 05/2013
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 01/2013
3	Leukemia 05/2017 - 02/2008
3	Residual Neoplasm 04/2016 - 09/2008
3	Thrombocytopenia (Thrombopenia) 02/2016 - 12/2009
3	Neutropenia 10/2013 - 12/2009
2	Sepsis (Septicemia) 01/2019 - 02/2016
2	Exanthema (Rash) 04/2017 - 11/2016
1	COVID-19 11/2023
1	Skin Neoplasms (Skin Cancer) 11/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Hyperthyroidism 01/2023
1	Frailty 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2021
1	Bites and Stings (Sting) 05/2020
1	Second Primary Neoplasms (Neoplasms, Second) 10/2019
1	Hypokalemia 01/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2019
1	Thromboembolism 01/2019
1	Body Weight (Weight, Body) 11/2018
1	Pathologic Complete Response 01/2018

Drug/Important Bio-Agent (IBA)

24	Rituximab (Mabthera)FDA Link 12/2023 - 07/2010
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 01/2016
10	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 08/2006
9	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 01/2016
8	Prednisone (Sone)FDA LinkGeneric 12/2023 - 01/2016
8	Lenalidomide (CC 5013)FDA Link 11/2023 - 02/2008
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2016
5	Monoclonal AntibodiesIBA 01/2020 - 08/2003
5	ibrutinibIBA 05/2017 - 01/2013
4	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2021
4	Calcineurin InhibitorsIBA 01/2018 - 02/2016
3	Agammaglobulinaemia Tyrosine KinaseIBA 12/2023 - 01/2013
3	temsirolimus FDA Link 01/2022 - 12/2009
3	Immune Checkpoint InhibitorsIBA 01/2020 - 11/2018
3	TOR Serine-Threonine KinasesIBA 09/2014 - 12/2009
3	Alemtuzumab (Campath)FDA Link 02/2011 - 08/2003
2	Bispecific AntibodiesIBA 01/2024 - 01/2024
2	CytokinesIBA 01/2024 - 01/2023
2	pembrolizumabIBA 01/2023 - 01/2019
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 01/2022
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2021 - 04/2017
2	Cell-Free Nucleic AcidsIBA 02/2021 - 10/2019
2	RadiumIBA 01/2021 - 01/2021
2	Bendamustine Hydrochloride FDA Link 05/2020 - 10/2019
2	ofatumumab FDA Link 01/2019 - 01/2017
2	B7-H1 AntigenIBA 01/2019 - 01/2019
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2018 - 02/2016
2	fludarabineIBA 01/2018 - 01/2018
2	Etoposide (VP 16)FDA LinkGeneric 12/2017 - 02/2016
2	idelalisibIBA 04/2017 - 09/2014
2	Bortezomib (Velcade)FDA Link 01/2016 - 10/2013
2	galiximabIBA 07/2013 - 10/2010
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	tisagenlecleucelIBA 11/2022
1	cc-486IBA 01/2022
1	AnthracyclinesIBA 01/2022
1	fimepinostatIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2021
1	polatuzumab vedotinIBA 05/2020
1	Immunoconjugates (Immunoconjugate)IBA 05/2020
1	tributyl phosphate (TBP)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	LigandsIBA 01/2019
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 12/2018
1	magrolimabIBA 11/2018
1	Dacarbazine (DIC)FDA LinkGeneric 10/2018
1	Brentuximab VedotinIBA 10/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2018
1	trans-crotonin (CTN)IBA 01/2018
1	Melphalan (Alkeran)FDA LinkGeneric 01/2018

Therapy/Procedure

42	Therapeutics 01/2024 - 07/2003
17	Cell Transplantation 01/2023 - 09/2013
14	Drug Therapy (Chemotherapy) 12/2023 - 07/2003
11	Transplantation 01/2021 - 08/2003
7	Stem Cell Transplantation 01/2019 - 07/2003
7	Homologous Transplantation 01/2018 - 08/2003
6	Autologous Transplantation 05/2019 - 08/2012
6	Hematopoietic Stem Cell Transplantation 01/2018 - 08/2003
4	Immunotherapy 01/2024 - 11/2014
4	Radioimmunotherapy 12/2023 - 09/2008
3	Radiotherapy 01/2016 - 07/2003
2	Aftercare (After-Treatment) 10/2019 - 01/2018
2	Combined Modality Therapy 12/2016 - 01/2016